Blog

Increased Risk for Melanoma in Men With Prostate Cancer: Implications for Clinical Practice?

Author and Disclosure Information

 

Prostate tumorigenesis is related to sex hormones, particularly androgens. It also has been suggested that melanoma may be androgen dependent. Postulated mechanisms of pathogenesis include androgen level imbalance (for which early evidence may present as severe teenaged acne), chromosome telomere length alteration (for which increased risk for melanoma is associated with long telomeres), and host immune response modification.

In a December 2013 article published in the Journal of Clinical Oncology, Li et al (2013;31:4394-4399) confirmed that a personal history of prostate cancer was associated with an increased risk for subsequent melanoma. Among patients with prostate cancer whose median age at diagnosis was 68 years or younger, a higher hazard ratio of melanoma was noted. Also, similar to prostate cancer, they observed a positive association between melanoma risk and severe teenaged acne defined by the use of tetracycline for 4 or more years.

What’s the issue?

Are there clinical implications to the confirmation that there is an increased risk for patients with prostate cancer to subsequently develop melanoma? Specifically, should there be increased surveillance for melanoma in these individuals? Perhaps it would be reasonable to regularly perform a complete skin examination in all patients with a history of prostate cancer, especially men who had prostate cancer diagnosed before 68 years of age.

We want to know your views! Tell us what you think.

Recommended Reading

New tanning bed technology no safer than the old
MDedge Dermatology
Blood test predicts Merkel cell carcinoma metastases
MDedge Dermatology
VIDEO: The DecisionDx-Melanoma test can predict metastasis of sentinel node-negative melanomas
MDedge Dermatology
Gene test predicts metastasis of sentinel node-negative melanomas
MDedge Dermatology
In situ melanoma high risk for subsequent diagnosis
MDedge Dermatology
Melanomas were less invasive at diagnosis in patients with established dermatologist
MDedge Dermatology
Immunotherapy for melanoma progresses with some interesting response patterns
MDedge Dermatology
New study supports imiquimod for lentigo maligna
MDedge Dermatology
What’s old is new again for actinic keratoses treatment
MDedge Dermatology
Substantial delay seen in melanoma surgery for Medicare patients
MDedge Dermatology

Related Articles